BetterLife Pharma Inc. (BETRF)

BetterLife Pharma Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	0.01	0.04	0.01	0.17	0.15
Cash & Short-Term Investments	0.01	0.04	0.01	0.17	0.15
Cash Growth	-78.12%	350.03%	-95.21%	12.14%	-94.23%
Other Receivables	0.01	0.04	0.02	0.32	0.52
Receivables	0.01	0.04	0.02	0.32	0.52
Prepaid Expenses	0.21	0.25	0.05	0.64	0.65
Total Current Assets	0.22	0.32	0.07	1.14	1.33
Property, Plant & Equipment	-	-	-	0.02	0.04
Total Assets	0.22	0.32	0.07	1.16	1.37
Accounts Payable	4.5	4.44	4.9	3.34	4.5
Accrued Expenses	1.48	1.6	1.39	0.14	0.66
Short-Term Debt	0.05	0.23	0.19	0.28	0.5
Current Portion of Long-Term Debt	0.82	-	-	-	-
Current Income Taxes Payable	-	-	-	0.16	-
Other Current Liabilities	0.7	0.55	0.67	0.22	0.18
Total Current Liabilities	7.54	6.83	7.15	4.14	5.85
Long-Term Debt	0.05	0.33	-	0.03	-
Other Long-Term Liabilities	-	0.87	0.46	0.86	0.13
Total Liabilities	7.59	8.02	7.61	5.04	5.98
Common Stock	79.97	78.46	76.57	75.38	63.67
Retained Earnings	-118.6	-115.08	-112.19	-103.17	-91.01
Comprehensive Income & Other	27.95	25.81	24.89	23.91	22.73
Total Common Equity	-10.68	-10.81	-10.73	-3.88	-4.61
Minority Interest	3.32	3.11	3.19	-	-
Shareholders' Equity	-7.36	-7.7	-7.53	-3.88	-4.61
Total Liabilities & Equity	0.22	0.32	0.07	1.16	1.37
Total Debt	0.92	0.56	0.19	0.31	0.5
Net Cash (Debt)	-0.91	-0.52	-0.18	-0.14	-0.35
Net Cash Per Share	-0.01	-0.00	-0.00	-0.00	-0.01
Filing Date Shares Outstanding	129.54	117.08	108.68	84.4	84.32
Total Common Shares Outstanding	129.54	115.83	90.1	85.24	51.45
Working Capital	-7.31	-6.5	-7.07	-3	-4.52
Book Value Per Share	-0.08	-0.09	-0.12	-0.05	-0.09
Tangible Book Value	-10.68	-10.81	-10.73	-3.88	-4.61
Tangible Book Value Per Share	-0.08	-0.09	-0.12	-0.05	-0.09
Machinery	-	-	-	0.04	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.